TELE-CONNECT: Telehealth Exercise for Continence After Gynaecological Cancer Treatment

Not Applicable

Recruiting

• Conditions: rinary incontinence; gynaecological cancer; Faecal incontinence; Urinary incontinence; Cancer - Womb (Uterine or endometrial cancer); Cancer - Cervical (cervix); Cancer - Ovarian and primary peritoneal; Cancer - Other cancer types

• Registration Number: ACTRN12622000580774
• Lead Sponsor: The University of Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-20
• Last Update Posted: 12 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 72

Inclusion Criteria

Women aged 18 years or more; following cancer treatment (with or without radiotherapy) for Stage I, II or III uterine, cervical, fallopian tube, primary peritoneal or ovarian cancer or borderline ovarian tumour; have the ability to speak and read English sufficiently for purposes of the study; have primary cancer treatment completed at least 6 months ago or adjuvant therapy completed at least 3 months ago; have self-reported urinary incontinence (at least 1 episode per week for last 4 weeks); have not received (in clinic or telehealth) >1 physiotherapy-supervised pelvic floor treatment session for urinary incontinence since commencing cancer treatment OR in the previous 4 years (whichever is most recent); and have a home internet connection and a smartphone.

Exclusion Criteria

Women who are pregnant or breastfeeding; have given birth within the last 12 months; have a severe pelvic organ prolapse; have a vaginal pessary ring in situ; have a significant neurological disorder; have a severe physical or psychiatric impairment; unable to participate in the e-health components of the study; have had pelvic surgery for incontinence or pelvic organ prolapse in the last 2 years; are not willing to use an intra-vaginal biofeedback device or videoconferencing software (Zoom or other) or are unable to give informed consent or complete all study and assessment procedures.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Impact of urinary incontinence: the International Consultation on Incontinence - Urinary Incontinence Short Form (ICIQ-UI SF)[ Baseline, and 17 (primary end-point) and 52 weeks post commencement of treatment]